Temporal arteritis, more formally called giant cell arteritis (GCA), usually requires a team of specialists rather than a single doctor. The condition involves inflammation of medium-to-large arteries, particularly those around the temples, and it can threaten your eyesight within days if left untreated. Because GCA affects blood vessels that serve the eyes, brain, and major organs, rheumatologists typically lead long-term management while ophthalmologists, neurologists, vascular surgeons, radiologists, pathologists, and pharmacists each play distinct roles at different stages. Understanding who does what can help you navigate a diagnosis that often feels urgent and confusing.
Your GP or Emergency Doctor Is Usually the Starting Point
Most people with suspected GCA first see a general practitioner or an emergency physician. A new, persistent headache in someone over fifty, scalp tenderness, jaw pain when chewing, or sudden vision changes are the red flags that should prompt immediate action. The critical job at this stage is recognizing the possibility of GCA and starting steroid treatment right away. Glucocorticoids remain the cornerstone of therapy and should be initiated immediately to prevent the most serious consequence of the disease: permanent blindness.1PubMed Central. Giant cell arteritis: Current treatment and management
This sounds straightforward, but it trips up many primary care doctors. A UK-wide study found that roughly one in five GPs said they would rule out GCA if headache was absent, and around a third did not routinely start glucocorticoids before referring the patient to a specialist.2BMJ Open. Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods study That matters because GCA does not always present with a classic headache. Some patients have jaw claudication, unexplained fevers, or weight loss without any head pain at all. The same study highlighted significant regional differences in how GPs manage suspected cases and where they send patients, with many GPs reporting that accessing specialist care was a challenge.
The takeaway for you as a patient is simple: if your doctor suspects GCA, steroids should not wait for a specialist appointment or a biopsy result. A delay of even a few days can make the difference between preserving and losing your sight.3The American Journal of Medicine. Temporal arteritis
Rheumatologists Lead Long-Term Care
Once the initial emergency is handled, a rheumatologist usually becomes the specialist managing your case going forward. GCA is classified as a vasculitis, a family of autoimmune diseases that attack blood vessels, and vasculitis is squarely within rheumatology’s territory. Rheumatologists decide how quickly to taper your steroids, monitor your inflammatory markers, watch for relapses, and determine whether you need additional medications.
This matters more than it might seem. A study comparing how rheumatologists and non-rheumatologists managed biopsy-proven GCA found meaningful differences: rheumatologists kept patients on adequate steroid doses for at least a month in over half of cases, versus only about a fifth under non-rheumatologists. Follow-up monitoring was also more regular when a rheumatologist was involved.4PubMed Central. Can rheumatologists diagnose and manage Giant Cell Arteritis better than non-rheumatologists? The Maltese Experience GCA treatment is not just about starting steroids. It is about managing a long, slow taper that can take a year or more, catching flares early, and preventing steroid-related complications. That kind of ongoing vigilance is what rheumatologists are trained for.
The confusion about where to refer patients is real. As one review in a general practice journal put it, localities need clear pathways for suspected GCA because GPs are often uncertain whether to refer to rheumatologists, ophthalmologists, or vascular surgeons.5British Journal of General Practice. Diagnosis and management of giant cell arteritis In practice, rheumatology is the home base for your ongoing care, but you will likely see other specialists for specific issues along the way.
Ophthalmologists Protect Your Vision
Vision loss is the complication people fear most, and with good reason. The most common way GCA damages eyesight is by inflaming the small arteries that feed the optic nerve, cutting off its blood supply. When someone over fifty develops sudden painless vision loss in one eye alongside signs of inflammation, that combination is treated as GCA until proven otherwise, and steroids are started without waiting for confirmatory tests.6PubMed. Vision loss in giant cell arteritis
An ophthalmologist or neuro-ophthalmologist (a specialist who focuses specifically on the intersection of eye and brain disease) is essential for evaluating visual symptoms, assessing how much damage has occurred, and monitoring the other eye. GCA-related vision loss is frequently irreversible once it happens, but treating aggressively can prevent the second eye from being affected. Even patients without visual symptoms at diagnosis sometimes get referred for a baseline eye exam, because subclinical damage can be happening without obvious signs.
If you are diagnosed with GCA, expect your ophthalmologist to remain involved for at least the initial months, particularly if you had any visual disturbance at presentation. Their job overlaps with the rheumatologist’s in the sense that both are watching for signs of active disease, but the ophthalmologist brings tools and expertise specific to detecting vascular damage in the retina and optic nerve that other specialists cannot replicate.
Surgeons and Pathologists Handle the Biopsy
A temporal artery biopsy has long been considered the gold standard for confirming GCA. The procedure involves a surgeon, typically a vascular surgeon or sometimes a general surgeon or ophthalmologic surgeon, removing a small segment of the temporal artery near the temple. It is usually done under local anesthetic as a minor outpatient procedure.
The decision about whether to biopsy is not always automatic. Understanding the disease process and the clinical picture helps a surgeon determine which patients will genuinely benefit from the procedure and which ones can be managed without it.7PubMed Central. The role of temporal artery biopsies in giant cell arteritis GCA inflammation can be patchy along the vessel wall, which means a biopsy can miss the affected segment entirely and return a false negative. Despite this limitation, a positive biopsy remains strong evidence for the diagnosis and can guide decisions about how aggressively to treat.
Once the tissue is removed, a pathologist examines it under a microscope. A consensus study among pathologists established which features should be reported: where inflammatory cells are located in the artery wall, whether granulomatous inflammation is present, and whether the inner lining of the vessel has thickened or the channel has narrowed or closed off entirely.8PubMed Central. Histopathology reporting of temporal artery biopsy specimens for giant cell arteritis: results of a modified Delphi study You will never meet the pathologist in person, but their report is often the piece of evidence that clinches the diagnosis.
Radiologists and the Ultrasound Alternative
Not everyone with suspected GCA needs a biopsy anymore. Vascular ultrasound has emerged as a non-invasive alternative that can strongly suggest the diagnosis. The key finding radiologists look for is the “halo sign,” a dark ring around the artery wall on ultrasound that indicates swelling. A large meta-analysis pooling data from over 2,700 patients found that the halo sign had a sensitivity of about 67% and a specificity of 95% when compared to clinical diagnosis with or without biopsy.9Rheumatology Advances in Practice. Role of the halo sign in the assessment of giant cell arteritis: a systematic review and meta-analysis
What those numbers mean in plain terms: if the halo sign is present, GCA is very likely. But because it misses about a third of cases, a negative ultrasound does not rule the disease out. This is why some centers use ultrasound as the first-line test and reserve biopsy for cases where the ultrasound is negative but clinical suspicion remains high. The approach varies by hospital and region, and part of what determines your pathway is which specialists and imaging equipment are available locally.
More advanced imaging such as PET-CT scans and MRI can also reveal GCA-related inflammation, particularly in larger arteries like the aorta that ultrasound handles less well. These imaging modalities are typically ordered by rheumatologists but read by radiologists, making the radiologist another behind-the-scenes specialist whose interpretation directly shapes your care.
When Neurologists Get Involved
Stroke is an uncommon but serious complication of GCA. When it happens, it tends to affect the arteries at the back of the brain, in the vertebrobasilar territory, and it is actually the leading cause of death in GCA patients who develop severe vascular complications.10PubMed Central. Stroke secondary to giant-cell arteritis: A literature review Neurologists are the specialists who manage stroke care and evaluate any neurological symptoms that arise during GCA, including cognitive changes, dizziness, or limb weakness.
GCA-related stroke can sometimes be the first presenting symptom, before any temple pain or jaw discomfort appears. In those cases, the neurologist managing the stroke might be the first to suspect GCA, particularly if duplex ultrasound performed as part of the stroke workup reveals the halo sign in the vertebral arteries. This is one reason GCA should be on the radar for any older adult presenting with stroke of unclear cause.
The underlying mechanism involves two distinct immune pathways that drive inflammation in the artery walls: one mediated by Th17 cells, which responds well to steroids, and another mediated by Th1 cells, which is less steroid-responsive.11PubMed Central. Th17 and Th1 T-cell responses in giant cell arteritis This dual-pathway biology helps explain why some patients develop complications even while on treatment: the steroids are suppressing one arm of the immune attack but not the other. Understanding this is relevant to anyone whose GCA seems to be controlled but who then develops new neurological symptoms.
Vascular Specialists for Aortic Monitoring
GCA does not just affect the temporal arteries. It can inflame the aorta, the body’s largest blood vessel, leading to aneurysms that develop silently over months or years. One study found a roughly 3% incidence of thoracic aortic aneurysm in GCA patients, with the ascending aorta being the most commonly affected site in the vast majority of those cases.12PubMed Central. Thoracic Aortic Aneurysm and Giant Cell Arteritis: Clarifying the Link Hypertension, smoking, and high cholesterol magnified the risk.
This is why many experts recommend ongoing imaging surveillance of the aorta in GCA patients, even after the acute disease has calmed down. A population-based study confirmed that GCA patients face an elevated risk of thoracic aortic complications, and that long-term monitoring should be part of the management plan.13Rheumatology. Increased risk of thoracic aortic complications among patients with giant cell arteritis: a nationwide, population-based cohort study A separate multicenter imaging study reinforced this conclusion, finding that early morphological imaging assessment and longitudinal monitoring of aortic dimensions are necessary in GCA patients.14Reumatismo. Aortic inflammation and aneurysm risk in giant cell arteritis: a multicenter imaging study
If an aneurysm is found, a vascular surgeon or cardiothoracic surgeon takes over that aspect of care. Small aneurysms may simply be watched with regular scans, while larger or rapidly growing ones can require surgical repair. This long-tail complication is the reason your care team may expand years after your initial GCA diagnosis.
The Overlap with Polymyalgia Rheumatica
If you have been diagnosed with GCA, there is a good chance you have also heard the term polymyalgia rheumatica (PMR). The two conditions are closely related and frequently overlap. In biopsy-proven GCA, PMR symptoms, primarily aching and stiffness in the shoulders, hips, and neck, show up in as many as half of patients. PMR can also be the first thing that brings someone to a doctor, before any cranial symptoms of GCA appear.15PubMed. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions
This overlap is relevant to which specialists you see because PMR is also managed by rheumatologists, and the steroid doses used for PMR alone are considerably lower than those used for GCA. If you are being treated for PMR and develop new headaches, jaw symptoms, or visual changes, your rheumatologist needs to know immediately, because the treatment strategy changes significantly. Patients who initially present with PMR sometimes get diagnosed with GCA months later once cranial symptoms emerge, which underscores why ongoing rheumatology follow-up matters even for what seems like a straightforward case of muscle aches.
Tocilizumab and the Changing Treatment Landscape
For decades, the only real treatment for GCA was high-dose steroids tapered slowly over a year or more. That has changed with the arrival of tocilizumab, a biologic drug that blocks the inflammatory signaling molecule interleukin-6. The GiACTA trial, a landmark phase 3 study, demonstrated that combining tocilizumab with a steroid taper allowed patients to maintain remission while accumulating substantially less total steroid exposure over three years compared to patients on steroids alone.16The Lancet Rheumatology. Long-term outcomes of tocilizumab for giant cell arteritis (GiACTA): extension of a phase 3, randomised, double-blind study A substantial proportion of patients treated with tocilizumab for one year maintained drug-free remission during the two years after stopping the medication.
Real-world data has backed this up. A retrospective study found that tocilizumab achieved complete disease remission in all patients studied and allowed the average steroid dose to be slashed from about 27 mg per day down to roughly 3 mg, with half of patients stopping steroids entirely.17PubMed. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study A head-to-head comparison of tocilizumab versus methotrexate, an older steroid-sparing drug, found that patients on tocilizumab reached steroid-free remission dramatically faster: about two-thirds were in sustained steroid-free remission at one year, compared to roughly one in nine on methotrexate.18PubMed Central. Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres
This shift means the rheumatologist managing your case may consult with or coordinate alongside an infusion center or clinical pharmacist experienced with biologic medications. Tocilizumab requires monitoring for side effects including infections and liver enzyme changes, and pharmacists play a practical role in tracking those issues and educating patients about warning signs to watch for.
Managing the Side Effects of Steroids
Even with tocilizumab available, most GCA patients still need steroids for at least the initial phase of treatment, and many remain on them for months. The side-effect profile of long-term glucocorticoids is well established and includes diabetes, osteoporosis, cataracts, and high blood pressure.19PubMed Central. The diagnosis and treatment of giant cell arteritis Additional risks include peptic ulcers, mood disturbances or psychosis, and increased susceptibility to infection.20PubMed. The Treatment of Giant Cell Arteritis
This means your care team often extends beyond the specialists treating the arteritis itself. You may need:
- Endocrinologist or GP: monitoring blood sugar and managing steroid-induced diabetes if it develops.
- Bone health specialist: calcium and vitamin D supplementation and sometimes bone-protective medications to counter osteoporosis.
- Gastroenterologist or GP: a proton pump inhibitor or similar medication to protect the stomach lining from ulcers.
The irony of GCA treatment is that the drug that saves your eyesight can cause a cascade of secondary health problems. A good rheumatologist anticipates these complications and either manages them directly or brings in the right colleagues proactively, rather than waiting for problems to appear.
Fast-Track Pathways and Why They Matter
One of the more encouraging developments in GCA care is the creation of fast-track pathways, which are coordinated systems designed to get patients from suspicion to specialist assessment and treatment as quickly as possible, usually within a day or two. A study evaluating a fast-track pathway found that after implementation, more than half of patients were treated within the first month of symptom onset, compared to roughly a fifth before the pathway existed. Patients who went through the fast-track system also had better final visual outcomes.21PubMed Central. Fast-track pathway for giant cell arteritis: Improved visual outcomes and reduced healthcare costs
These pathways typically involve a GP or emergency doctor recognizing the red flags, immediately starting steroids, and simultaneously booking same-day or next-day appointments for ultrasound and specialist assessment. The specialist might be a rheumatologist, an ophthalmologist, or both, depending on local resources. The fast-track model treats GCA the way emergency departments treat heart attacks: as a time-sensitive condition where delays have irreversible consequences.
Not every region has a fast-track pathway yet, and availability varies widely. If you suspect GCA and your local system does not have one, being persistent about the urgency of your symptoms can make a real difference. The key message to communicate to any doctor is that GCA is an emergency for your eyes, and waiting weeks for a referral is not acceptable.
Living with GCA After the Acute Phase
The specialist involvement does not end once your inflammation is controlled. Research into the patient experience of GCA has identified dozens of distinct ways the disease and its treatment affect daily life, spanning physical symptoms, daily activities, psychological impact, and even a person’s sense of identity and self-perception.22PubMed Central. Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure Roughly a third to half of patients report lasting physical or mental disability attributable to GCA and its treatment in the months or years following diagnosis.23PubMed Central. Impact of Giant Cell Arteritis and Its Treatment on the Patient’s Quality of Life: A Single-Center Self-Assessment Study
Fatigue is one of the most common lingering complaints, and it is not always clear whether it comes from the disease itself, the steroids, or both. Weight gain, mood changes, sleep disruption, and muscle weakness from prolonged steroid use are common enough that patients sometimes feel the treatment is nearly as burdensome as the disease. Some patients benefit from referral to a psychologist or mental health professional, particularly if the diagnosis involved sudden vision loss or a protracted course with multiple relapses.
Practically speaking, your long-term care team for GCA might include a rheumatologist for disease monitoring, an ophthalmologist for eye checks, a vascular specialist reviewing periodic imaging of your aorta, a GP managing steroid side effects and general health, and a pharmacist helping to coordinate medications and flag interactions. That sounds like a lot of doctors, and it is. But each one is watching for a different complication, and the conditions they are trying to prevent, from blindness to aortic rupture, are serious enough to justify the effort.